ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681635 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681635; 2) Community: the network communities that were significantly associated with the response to NSC 681635; 3) Molecule: the relationships between components within communities and NSC 681635; 4) MDR: the compounds that were significantly associated with the NSC 681635.

NSC Compound Enrichment Correlation
NSC 76356 Adenine, 9-.beta.-D-arabinofuranosyl-2-chloro- (8CI) 0.0382675857669588 0.51900777
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 0.0382675857669588 0.32751967
NSC 700455 Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- 0.0414190425892865 0.20284645
NSC 726267 Null 0.0414190425892865 0.35701091
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0414190425892865 0.039201146
NSC 736157 Null 0.0414190425892865 0.19798891
NSC 740 Methotrexate 0.0414190425892865 0.50179471
NSC 748712 Null 0.0414190425892865 0.36652261
NSC 758119 (1R,6S,11aS,13S,14aR)-1,13-dihydroxy-6-vinyl-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-4-one 0.0414190425892865 -0.2407503
NSC 762559 Null 0.0414190425892865 0.20108794
Total:58  Current:48    [First] [Prev] [Next] [Last]